Reports Q4 revenue $35.56B, consensus $35.41B. "Our disciplined focus in 2022 allowed us to successfully execute on foundational work that will support our long-term growth strategy. We also delivered strong financial results, exceeding our most recent full year guidance," said Sarah London, CEO of Centene. "This positive momentum positions us well for 2023 and beyond as we maximize the opportunities ahead for our core business."
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on CNC:
- CENTENE CORPORATION REPORTS 2022 RESULTS
- Notable companies reporting before tomorrow’s open
- Managed care stocks pressured after CMS’ preliminary Medicare Advantage rates
- Medicare Advantage final rule more favorable than feared, says JPMorgan
- Centene completes divestiture of Magellan Specialty Health to Evolent Health
